Institution · Saskatchewan Cancer Agency

Most cited papers from Saskatchewan Cancer Agency

Saskatchewan Cancer Agency

What are the most cited papers from Saskatchewan Cancer Agency?

The most cited paper from Saskatchewan Cancer Agency is "Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma" (James Edward Krook, C G Moertel, Leonard L. Gunderson et al., 1991), with 1,905 citations. Next come "Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial" (1,160) and "Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study" (1,083).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 61 papers. Every paper with more than 110 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma James Edward Krook, C G Moertel, Leonard L. Gunderson et al. · New England Journal of Medicine	14 Mar 1991	1,905
2	Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé et al. · Journal of Clinical Oncology Open access	28 Oct 2014	1,160
3	Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study Melina Arnold et al. · The Lancet Oncology Open access	11 Sep 2019	1,083
4	Adjuvant Docetaxel for Node-Positive Breast Cancer Miguel Martín et al. · New England Journal of Medicine Open access	Jun 2005	957
5	Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001 Paul David Brown et al. · Journal of Clinical Oncology Open access	14 Feb 2020	858
6	Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management Sukanya Pati, Wadeed Irfan, Ahmed Tariq Jameel et al. · Cancers Open access	12 Jan 2023	659
7	Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer Eric Xueyu Chen et al. · JAMA Oncology Open access	7 May 2020	405
8	Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries Shu‐Chun Chuang, Ghislaine Scélo, Jon M. Tonita et al. · International Journal of Cancer	26 Aug 2008	300
9	Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221) Christine B. Ambrosone, Gary Zirpoli, Alan David Hutson et al. · Journal of Clinical Oncology Open access	19 Dec 2019	250
10	Comparing deep learning-based auto-segmentation of organs at risk and clinical target volumes to expert inter-observer variability in radiotherapy planning Jordan Wong, Allan Fong, Nevin McVicar et al. · Radiotherapy and Oncology	5 Dec 2019	249
11	Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T‐lymphocyte responses and antitumour immunity Siguo Hao, Ou Bai, Fang Li et al. · Immunology Open access	31 Oct 2006	244
12	Risk of second cancer among women with breast cancer Lene Mellemkjær, Søren Friis, Jørgen H. Olsen et al. · International Journal of Cancer	8 Dec 2005	232
13	Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy Julie E. Hammack, John C. Michalak, Charles L. Loprinzi et al. · Pain	Jul 2002	231
14	Radiation Dose and Leukemia Risk in Patients Treated for Cancer of the Cervix John D. Boice et al. · JNCI Journal of the National Cancer Institute	Dec 1987	231
15	Power-Frequency Electric and Magnetic Fields and Risk of Childhood Leukemia in Canada Mary L. McBride, Richard P. Gallagher, Guylène Thériault et al. · American Journal of Epidemiology	May 1999	219
16	Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicine Thierry Burnouf, Hadi Alphonse Goubran, Ming‐Li Chou et al. · Blood Reviews	21 Apr 2014	214
17	Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience Lucie Lafay‐Cousin, Cynthia E Hawkins, Anne‐Sophie Carret et al. · European Journal of Cancer	27 Oct 2011	214
18	Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer Maurice M. Black, Thomas H. C. Barclay, Sidney J. Cutler et al. · Cancer Open access	Feb 1972	209
19	A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand et al. · Cancer Open access	15 May 1990	208
20	Regulation of Tumor Growth and Metastasis: The Role of Tumor Microenvironment Hadi Alphonse Goubran, Rami Kotb, Julie Stakiw et al. · Cancer Growth and Metastasis Open access	2014	202
21	Malignant tumors of the small intestine Thomas H. C. Barclay, David V. Schapira · Cancer Open access	Mar 1983	195
22	Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase Ryaz Chagpar, Philip H. Links, Miryam Pastor et al. · Proceedings of the National Academy of Sciences Open access	8 Mar 2010	193
23	Second Primary Cancers in Thyroid Cancer Patients: A Multinational Record Linkage Study Thekkepat C. Sandeep, Mark W. J. Strachan, Rebecca M. Reynolds et al. · The Journal of Clinical Endocrinology & Metabolism Open access	15 Feb 2006	192
24	Diabetes and Cancer: Risk, Challenges, Management and Outcomes Rabia K. Shahid, Shahid Ahmed, Duc Le et al. · Cancers Open access	16 Nov 2021	189
25	Living with Hope: Initial Evaluation of a Psychosocial Hope Intervention for Older Palliative Home Care Patients Wendy Duggleby, Lesley Faith Degner, Allison Williams et al. · Journal of Pain and Symptom Management Open access	Mar 2007	189
26	HER2-directed therapy: current treatment options for HER2-positive breast cancer Shahid Ahmed, Amer Sami, Jim Xiang · Breast Cancer	29 Jan 2015	185
27	Prognosis in breast cancer utilizing histologic characteristics of the primary tumor Maurice M. Black, Thomas H. C. Barclay, Benjamin F. Hankey · Cancer	Dec 1975	174
28	Membrane‐bound HSP70‐engineered myeloma cell‐derived exosomes stimulate more efficient CD8+ CTL‐ and NK‐mediated antitumour immunity than exosomes released from heat‐shocked tumour cells expressing cytoplasmic HSP70 Yufeng Xie, Ou Bai, Haifeng Zhang et al. · Journal of Cellular and Molecular Medicine Open access	20 Jul 2009	170
29	Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: Vitamin D as a possible explanation Pentti Tuohimaa, Eero Pukkala, Ghislaine Scélo et al. · European Journal of Cancer	31 May 2007	168
30	Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer Steven E. Schild, James A. Bonner, Thomas G. Shanahan et al. · International Journal of Radiation OncologyBiologyPhysics	Jul 2004	168
31	SRC gene expression in human cancer: the role of transcriptional activation Scott M. Dehm, Keith Bonham · Biochemistry and Cell Biology	Apr 2004	166
32	Ratios of involved nodes in early breast cancer Vincent Vinh‐Hung, Claire F. Verschraegen, Donald I. Promish et al. · Breast Cancer Research Open access	6 Oct 2004	166
33	Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells Zhuang Chen, Terence N. Moyana, Anurag Saxena et al. · International Journal of Cancer Open access	2001	159
34	The platelet–cancer loop Hadi Alphonse Goubran, Thierry Burnouf, Mirjana Radosevic et al. · European Journal of Internal Medicine	21 Feb 2013	158
35	Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer Margot J. Burnell, Mark N. Levine, Judith‐Anne W. Chapman et al. · Journal of Clinical Oncology Open access	10 Nov 2009	155
36	Mechanisms of cellular communication through intercellular protein transfer Khawaja Ashfaque Ahmed, Jim Xiang · Journal of Cellular and Molecular Medicine Open access	11 Jan 2010	155
37	A New Dynamic Model of CD8+ T Effector Cell Responses via CD4+ T Helper-Antigen-Presenting Cells Jim Xiang, Hui Huang, Yongqing Liu · The Journal of Immunology	Jun 2005	153
38	Current status of immunotherapy in metastatic colorectal cancer Paweł Wróbel, Shahid Ahmed · International Journal of Colorectal Disease	21 Nov 2018	149
39	Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease Shahid Ahmed, Steven J. Kussick, Anita K. Siddiqui et al. · European Journal of Cancer	21 Apr 2004	146
40	Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors Shawn C. Chafe, Frederick S. Vizeacoumar, Geetha Venkateswaran et al. · Science Advances Open access	27 Aug 2021	142
41	AI is a viable alternative to high throughput screening: a 318-target study The Atomwise AIMS Program et al. · Scientific Reports Open access690 authors	2 Apr 2024	139
42	Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study Sean McPhail et al. · The Lancet Oncology Open access	6 Apr 2022	136
43	Prostate Cancer Incidence and Mortality Rates and Trends in the United States and Canada Kathleen McDavid, Judy J. Lee, John P Fulton et al. · Public Health Reports	Mar 2004	136
44	Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study Wai‐Kuen Ho, WI Wei, Dora L.�W. Kwong et al. · Head & Neck	Sep 1999	135
45	Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes. Siguo Hao, Ou Bai, Jinying Yuan et al. · PubMed	Jun 2006	132
46	Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32 Pamela Jean Goodwin, Wendy R. Parulekar, Karen A. Gelmon et al. · JNCI Journal of the National Cancer Institute Open access	4 Mar 2015	132
47	QOLLTI-F: measuring family carer quality of life S. Robin Cohen, Anne M. Leis, David R. Kuhl et al. · Palliative Medicine	Dec 2006	130
48	SH3 Binding Motif 1 in Influenza A Virus NS1 Protein Is Essential for PI3K/Akt Signaling Pathway Activation Yeun‐Kyung Shin, Yang Li, Qiang Liu et al. · Journal of Virology Open access	20 Sep 2007	130
49	Dendritic Cells Recruit T Cell Exosomes via Exosomal LFA-1 Leading to Inhibition of CD8+ CTL Responses through Downregulation of Peptide/MHC Class I and Fas Ligand-Mediated Cytotoxicity Yufeng Xie, Haifeng Zhang, Wei Li et al. · The Journal of Immunology Open access	30 Sep 2010	130
50	Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study Anamaria Reyna Yeung et al. · Journal of Clinical Oncology Open access	19 Feb 2020	129

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.